Literature DB >> 27085714

Angiotensin II regulation of angiotensin-converting enzymes in spontaneously hypertensive rat primary astrocyte cultures.

Yugandhar V Gowrisankar1, Michelle A Clark1.   

Abstract

Angiotensin (Ang) II plays a critical role in cardiovascular and blood pressure regulation. Ang II is produced by angiotensin-converting enzyme (ACE) and it interacts with the Ang AT1 receptor to cause much of its well-known cardiovascular effects. Ang-(1-7) is another active peptide produced by the rennin-angiotensin system. This peptide is produced from Ang I or Ang II by the catalytic activity of ACE2. Ang-(1-7) interacts with the Mas receptor to counteract many of the effects of Ang II. Thus, the ACE2/Ang-(1-7)/Mas axis acts opposite of the ACE/Ang II/AT1 axis. In this study we investigated how Ang II regulates the key enzymes of these axes, ACE and its homolog ACE2, and determined whether they are dysregulated in the hypertensive condition. Brainstem and cerebellum astrocytes isolated from the spontaneously hypertensive rat (SHR) were used in these studies. Ang II effect on the enzymes' mRNA and protein levels was measured using quantitative PCR and western blotting techniques, respectively. Results from this study showed that Ang II up-regulated ACE protein levels, but down-regulated ACE mRNA levels in brainstem and cerebellum astrocytes in both models. Ang II also reduced ACE2 mRNA expression in SHR and Wistar astrocytes isolated from both brain regions. Ang II effects on ACE2 protein were biphasic. In SHR astrocytes, Ang II-mediated ACE2 protein initially increased then decreased at later time points. In contrast, in Wistar astrocytes, Ang II initially decreased ACE2 protein expression, but up-regulated the protein at later time points. The findings of these studies suggest that Ang II has a differential effect on ACE and ACE2 expression. Furthermore, in the SHR model there may be alteration in the ACE/ACE2 balance in a manner that favors increased Ang II generation and decreased Ang-(1-7) production contributing to the hypertensive phenotype observed in this model. The levels of angiotensin (Ang) II depend on the actions of angiotensin-converting enzyme (ACE) and ACE2. We showed in astrocytes isolated from the SHRs that Ang II differentially affects ACE and ACE2 expression. There may be an alteration in the ACE/ACE2 balance favoring Ang II generation. This imbalance may contribute to the hypertensive phenotype observed in this SHR model.
© 2016 International Society for Neurochemistry.

Entities:  

Keywords:  angiotensin II; angiotensin-converting enzyme; astrocytes; brainstem; cerebellum

Mesh:

Substances:

Year:  2016        PMID: 27085714     DOI: 10.1111/jnc.13641

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  38 in total

Review 1.  Astrocytes and the Renin Angiotensin System: Relevance in Disease Pathogenesis.

Authors:  Ann Tenneil O'Connor; Michelle A Clark
Journal:  Neurochem Res       Date:  2018-06-01       Impact factor: 3.996

Review 2.  COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside.

Authors:  David Sulzer; Angelo Antonini; Valentina Leta; Anna Nordvig; Richard J Smeyne; James E Goldman; Osama Al-Dalahmah; Luigi Zecca; Alessandro Sette; Luigi Bubacco; Olimpia Meucci; Elena Moro; Ashley S Harms; Yaqian Xu; Stanley Fahn; K Ray Chaudhuri
Journal:  NPJ Parkinsons Dis       Date:  2020-08-20

Review 3.  Rationale for 1068 nm Photobiomodulation Therapy (PBMT) as a Novel, Non-Invasive Treatment for COVID-19 and Other Coronaviruses: Roles of NO and Hsp70.

Authors:  Lydia C Kitchen; Marvin Berman; James Halper; Paul Chazot
Journal:  Int J Mol Sci       Date:  2022-05-07       Impact factor: 6.208

4.  Age-dependent alterations to paraventricular nucleus insulin-like growth factor 1 receptor as a possible link between sympathoexcitation and inflammation.

Authors:  Olalekan M Ogundele; Charles C Lee; Joseph Francis
Journal:  J Neurochem       Date:  2016-10-19       Impact factor: 5.372

Review 5.  Potential Neurologic Manifestations of COVID-19.

Authors:  Anna S Nordvig; Kathryn T Fong; Joshua Z Willey; Kiran T Thakur; Amelia K Boehme; Wendy S Vargas; Craig J Smith; Mitchell S V Elkind
Journal:  Neurol Clin Pract       Date:  2021-04

6.  Immunohistochemical expression of intrarenal renin angiotensin system components in response to tempol in rats fed a high salt diet.

Authors:  Gabriel Cao; Silvana Lorena Della Penna; Nicolás Martín Kouyoumdzian; Marcelo Roberto Choi; Susana Gorzalczany; Belisario Enrique Fernández; Jorge Eduardo Toblli; María Inés Rosón
Journal:  World J Nephrol       Date:  2017-01-06

7.  Association between ACE2/ACE balance and pneumocyte apoptosis in a porcine model of acute pulmonary thromboembolism with cardiac arrest.

Authors:  Hong-Li Xiao; Lian-Xing Zhao; Jun Yang; Nan Tong; Le An; Qi-Tong Liu; Miao-Rong Xie; Chun-Sheng Li
Journal:  Mol Med Rep       Date:  2018-01-12       Impact factor: 2.952

Review 8.  Coronavirus disease 2019 (COVID-19) pathogenesis: a concise narrative review.

Authors:  Hamza Elhamzaoui; Houssam Rebahi; Abdelhamid Hachimi
Journal:  Pan Afr Med J       Date:  2021-05-03

Review 9.  Psychiatric face of COVID-19.

Authors:  Luca Steardo; Luca Steardo; Alexei Verkhratsky
Journal:  Transl Psychiatry       Date:  2020-07-30       Impact factor: 6.222

Review 10.  Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).

Authors:  Arno R Bourgonje; Amaal E Abdulle; Wim Timens; Jan-Luuk Hillebrands; Gerjan J Navis; Sanne J Gordijn; Marieke C Bolling; Gerard Dijkstra; Adriaan A Voors; Albert Dme Osterhaus; Peter Hj van der Voort; Douwe J Mulder; Harry van Goor
Journal:  J Pathol       Date:  2020-06-10       Impact factor: 9.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.